Iran vs Pacific island small states: Immunization, HepB3 (% of one-year-old children)
Iran
98.0%
in 2024
Pacific island small states
87.0%
in 2024
Iran rank
19th
Pacific island small states rank
19th
Immunization, HepB3 (% of one-year-old children) over time
- Iran
- Pacific island small states
How they compare
Iran currently reports 98.0% against 87.0% in Pacific island small states, a difference of 11.0%.
That makes Iran's figure about 1.1 times Pacific island small states's.
The two have swapped places 1 time across 31 shared years of data; in 1994 it was Pacific island small states ahead.
Iran ranks 19th and Pacific island small states ranks 19th of 188 countries.
Across the 4 decades both report, Iran averaged higher in 3 and Pacific island small states in 1.
Head to head by decade
| Decade | Iran | Pacific island small states | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 81.2% | 82.1% | 0.9% | Pacific island small states |
| 2000s | 97.2% | 86.5% | 10.7% | Iran |
| 2010s | 98.8% | 88.7% | 10.1% | Iran |
| 2020s | 98.6% | 88.0% | 10.6% | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, Iran or Pacific island small states?
- Iran, at 98.0% against 87.0% in Pacific island small states as of 2024.
- What is the difference in immunization, hepb3 between Iran and Pacific island small states?
- 11.0%, with Iran ahead.
- How many years of comparable data are there for Iran and Pacific island small states?
- 31 years are reported by both, from 1994 to 2024.
- How do Iran and Pacific island small states rank globally for immunization, hepb3?
- Iran ranks 19th and Pacific island small states ranks 19th of 188 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.